medullary thyroid cancer and glp 1 Frontiers GLP-1 medications and thyroid cancer
Description
doi: 10.1007/s10787-024-01556-2
Their clinical benefits are undeniable
But it is an uphill battle

While GLP-1 receptors are present in the hippocampus and preclinical studies suggest potential cognitive benefits, there is currently no FDA-approved indication for GLP-1 medications in cognitive disorders or neuroprotection

Helpful links and resources: Learn about our guests here: IG: @drkelleychew and @brightlineeating Sign up for Dr Lauren's Biohacking for the Rest of Us newsletter here

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD)
